Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.

导出 OA

翻译打印收藏纠错

第一作者： Panagiota,Xanthouli

第一单位： Centre for Pulmonary Hypertension at Thoraxklinik gGmbH at Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany.

作者： Panagiota,Xanthouli ^[1] ; Maria,Koegler ^[2] ; Alberto M,Marra ^[1] ; Nicola,Benjamin ^[2] ; Lukas,Fischer ^[3] ; Christina A,Eichstaedt ^[1] ; Satenik,Harutyunova ^[2] ; Christian,Nagel ^[1] ; Ekkehard,Grünig ^[2] ; Benjamin,Egenlauf ^[1]

作者单位： Centre for Pulmonary Hypertension at Thoraxklinik gGmbH at Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany. ^[1] Translational Lung Research Centre Heidelberg (TLRC), German Centre for Lung Research (DZL), Heidelberg, Germany. ^[2] IRCCS SDN, Naples, Italy. ^[3] Laboratory for Molecular Genetic Diagnostics, Institute of Human Genetics, Heidelberg University, Heidelberg, Germany. ^[4] Lung Centre, Klinikum Mittelbaden, Baden-Baden Balg, Baden-Baden, Germany. ^[5] Centre for Pulmonary Hypertension at Thoraxklinik gGmbH at Heidelberg University Hospital, Röntgenstraße 1, 69126, Heidelberg, Germany. benjamin.egenlauf@med.uni-heidelberg.de. ^[6] Translational Lung Research Centre Heidelberg (TLRC), German Centre for Lung Research (DZL), Heidelberg, Germany. benjamin.egenlauf@med.uni-heidelberg.de. ^[7]

关键词 Comorbidities Pulmonary arterial hypertension Risk stratification Survival Time to clinical worsening